Electromed (AMEX: ELMD) reported a record fourth-quarter earnings per share (EPS) of $0.39, beating analyst consensus estimates of $0.32 by 21.88 percent.

The company also posted quarterly sales of $19.4 million, slightly exceeding the consensus estimate of $19.333 million by 0.43 percent. In a significant leadership update, President and CEO Jim Cunniff announced his planned retirement for April 2027.

Financial Performance

Electromed’s quarterly results reflect growth in both profitability and top-line revenue compared to the same period last year. The quarter marked the company's 15th consecutive quarter of year-over-year revenue and profit growth.

Earnings per share increased 56 percent from $0.25 in the corresponding quarter of the previous fiscal year. Sales grew 11.6 percent year-over-year from $17.393 million.

Full-Year Results

For fiscal 2026, Electromed achieved record annual revenues of $73.0 million, a 15.3 percent increase from $64.0 million in fiscal 2025. Gross profit rose to $57.9 million, representing a gross margin of 78.5 percent, up from 78.1 percent in the prior year.

Operating income for the full year reached $13.9 million, or 18.8 percent of net revenues, compared to $9.7 million, or 15.1 percent, in fiscal 2025. This represents a 43.7 percent growth in operating income. Full-year diluted EPS was $1.30.

Operational Highlights

Growth was primarily driven by the core home care channel, which grew 15 percent in the quarter. The company expanded its direct sales force to 64 representatives, preparing for territory expansions in fiscal 2027. Home care revenue per weighted average direct sales representative in fiscal 2026 was $1,145,000, exceeding the target range of $1,000,000 to $1,100,000.

Hospital revenue declined 29 percent in the quarter due to longer sales cycles. However, the company maintains a "hospital as a gateway to the home" strategy. Payer coverage expanded significantly, with 87 percent of U.S. covered lives under contract, adding 40 new payer contracts and over 6 million covered lives during the year.

Leadership Transition

CEO Jim Cunniff announced his retirement, effective April 2027. He cited a strong track record of building the business and developing a talented leadership team. A succession plan led by the board is in place to ensure a smooth transition.

What the Numbers Show

The divergence between the modest sales beat (0.43 percent) and the significant EPS beat (21.88 percent) underscores substantial operating leverage. Operating income grew 43.7 percent annually while revenue grew only 15.3 percent, indicating that cost management and efficiency gains are driving profitability more than top-line expansion alone. Additionally, the debt-free balance sheet with $20.0 million in cash provides flexibility for continued reinvestment and share repurchases.

Electromed, Inc. (NYSE American: ELMD) announced that President and Chief Executive Officer Jim Cunniff expects to retire on or about April 2, 2027.

Upon his retirement, Cunniff will also resign from the Company’s Board of Directors. The Board intends to conduct a national search for Electromed’s next President and Chief Executive Officer.

Succession Planning

The Board has engaged an executive search firm to assist in identifying a successor for the top role. No timeline for the completion of the search was disclosed.

Electromed is a leader in innovative airway clearance technologies.